Status: current, Defined. Date: 31-Jan 2022. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4664611000168110 | tozinameran 30 microgram / 0.3 mL injection, 195 x 2.25 mL vials (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4664621000168115 | tozinameran 30 microgram/0.3 mL injection, 195 x 2.25 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
4665281000168117 | COVID-19 BNT162b2 mRNA adolescent/adult vaccine injection, 195 x 2.25 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
4665291000168119 | BNT162b2 mRNA encoding SARS-CoV-2 spike protein 30 microgram/0.3 mL injection, 195 x 2.25 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
4665301000168118 | BNT162b2 mRNA (messenger ribonucleic acid) encoding SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) spike glycoprotein 30 microgram/0.3 mL injection, 195 x 2.25 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
tozinameran 30 microgram/0.3 mL injection, 195 x 2.25 mL vials | Is a | medicinal product pack | true | Inferred relationship | Some | ||
tozinameran 30 microgram/0.3 mL injection, 195 x 2.25 mL vials | has MPUU | tozinameran 30 microgram/0.3 mL injection, 2.25 mL vial | true | Inferred relationship | Some | 1767422615 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Comirnaty Grey Cap 12 Years and Above Ready to Use Multidose 30 microgram/0.3 mL injection, 195 x 2.25 mL vials | Is a | True | tozinameran 30 microgram/0.3 mL injection, 195 x 2.25 mL vials | Inferred relationship | Some |
Reference Sets
List of Excluded Medicinal Items reference set
Medicinal product pack reference set